Franklin Resources’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.2M | Sell |
186,099
-258
| -0.1% | -$29.3K | 0.01% | 906 |
|
|
2025
Q1 | $19.6M | Buy |
186,357
+955
| +0.5% | +$100K | 0.01% | 902 |
|
|
2024
Q4 | $19.9M | Buy |
185,402
+90,743
| +96% | +$9.72M | 0.01% | 914 |
|
|
2024
Q3 | $9.79M | Buy |
94,659
+78,973
| +503% | +$8.17M | ﹤0.01% | 1131 |
|
|
2024
Q2 | $1.32M | Buy |
15,686
+1,747
| +13% | +$147K | ﹤0.01% | 1822 |
|
|
2024
Q1 | $1.02M | Sell |
13,939
-127
| -0.9% | -$9.28K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $1M | Buy |
14,066
+438
| +3% | +$31.3K | ﹤0.01% | 1635 |
|
|
2023
Q3 | $817K | Buy |
13,628
+4,191
| +44% | +$251K | ﹤0.01% | 1683 |
|
|
2023
Q2 | $680K | Buy |
+9,437
| New | +$680K | ﹤0.01% | 1807 |
|
|
2022
Q3 | – | Sell |
-2,275
| Closed | -$203K | – | 2356 |
|
|
2022
Q2 | $203K | Sell |
2,275
-297
| -12% | -$26.5K | ﹤0.01% | 2016 |
|
|
2022
Q1 | $290K | Buy |
2,572
+31
| +1% | +$3.5K | ﹤0.01% | 2025 |
|
|
2021
Q4 | $392K | Buy |
2,541
+192
| +8% | +$29.6K | ﹤0.01% | 1994 |
|
|
2021
Q3 | $328K | Buy |
2,349
+791
| +51% | +$110K | ﹤0.01% | 2052 |
|
|
2021
Q2 | $204K | Buy |
1,558
+100
| +7% | +$13.1K | ﹤0.01% | 1844 |
|
|
2021
Q1 | $223K | Buy |
+1,458
| New | +$223K | ﹤0.01% | 1784 |
|